Malcolm C. Kendall
Fondatore presso Microbiome Insights, Inc.
Posizioni attive di Malcolm C. Kendall
Società | Posizione | Inizio | Fine |
---|---|---|---|
Microbiome Insights, Inc.
Microbiome Insights, Inc. Miscellaneous Commercial ServicesCommercial Services Microbiome Insights, Inc. provides analysis and testing services for academic and industrial researchers. The firm’s services include experimental design consultation, sample extraction, nucleic acid processing and analysis as required (cdna generation, pcr, sequencing, etc.), basic data analysis, advanced data analysis, data and sample storage and submission to public databases. The company was founded by Malcolm C. Kendall, Barton B. Finlay and Bill Mohn in 2015 and is headquartered in Vancouver, Canada. | Direttore/Membro del Consiglio | 01/01/2015 | - |
Amministratore Delegato | 01/01/2015 | - | |
Fondatore | 01/01/2015 | - |
Storia della carriera di Malcolm C. Kendall
Precedenti posizioni note di Malcolm C. Kendall
Società | Posizione | Inizio | Fine |
---|---|---|---|
Indel Therapeutics, Inc.
Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | Amministratore Delegato | - | - |
Fondatore | - | - | |
Presidente | - | - | |
Twinstrand Therapeutics, Inc.
Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Twinstrand Therapeutics Inc. manufactures and distributes biological drugs. It focuses on discovering, developing and commercializing of therapeutics for the treatment of cancer, hepatitis A, cytomegalovirus, malaria, schistosomiasis, and fungal diseases. The company was founded in 1995 and is located in North Vancouver, Canada. | Direttore/Membro del Consiglio | - | - |
Inimex Pharmaceuticals, Inc.
Inimex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inimex Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of Innate Defense Regulators (IDRs). IDRs are novel drugs that selectively trigger the body's innate defenses, protecting against antibiotic-resistant infections and controlling inflammation. The company was founded in 2001 and is headquartered in Vancouver, Canada. | Direttore/Membro del Consiglio | - | - |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Corporate Officer/Principal | - | - |
Formazione di Malcolm C. Kendall
Washington & Lee University | Undergraduate Degree |
The University of North Carolina at Charlotte | Masters Business Admin |
Statistiche
Distribuzione geografica
Canada | 6 |
Stati Uniti | 3 |
Posizioni
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Founder | 2 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 5 |
---|---|
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Finance |
Twinstrand Therapeutics, Inc.
Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Twinstrand Therapeutics Inc. manufactures and distributes biological drugs. It focuses on discovering, developing and commercializing of therapeutics for the treatment of cancer, hepatitis A, cytomegalovirus, malaria, schistosomiasis, and fungal diseases. The company was founded in 1995 and is located in North Vancouver, Canada. | Health Technology |
Inimex Pharmaceuticals, Inc.
Inimex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inimex Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of Innate Defense Regulators (IDRs). IDRs are novel drugs that selectively trigger the body's innate defenses, protecting against antibiotic-resistant infections and controlling inflammation. The company was founded in 2001 and is headquartered in Vancouver, Canada. | Health Technology |
Microbiome Insights, Inc.
Microbiome Insights, Inc. Miscellaneous Commercial ServicesCommercial Services Microbiome Insights, Inc. provides analysis and testing services for academic and industrial researchers. The firm’s services include experimental design consultation, sample extraction, nucleic acid processing and analysis as required (cdna generation, pcr, sequencing, etc.), basic data analysis, advanced data analysis, data and sample storage and submission to public databases. The company was founded by Malcolm C. Kendall, Barton B. Finlay and Bill Mohn in 2015 and is headquartered in Vancouver, Canada. | Commercial Services |
Indel Therapeutics, Inc.
Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | Health Technology |
- Borsa valori
- Insiders
- Malcolm C. Kendall
- Esperienza